Phase II Study of Loading-Dose Ibandronate Treatment in Patients with Breast Cancer and Bone Metastases Suffering from Moderate to Severe Pain

Publisher： Karger

E-ISSN： 2296-5262|35|5|254-258

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.35, Iss.5, 2012-04, pp. : 254-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diagnosis, Management and Clinical Outcome of Bone Metastases in Breast Cancer Patients: Results from a Prospective, Multicenter Study

By  

Oncology, Vol. 71, Iss. 5-6, 2007-09 ,pp. : 374-381

Karger

Access to resources Recommend Favorite

Strontium-89 Chloride in the Treatment of Bone Metastases from Breast Cancer

By  

Oncology, Vol. 55, Iss. 5, 1998-08 ,pp. : 377-381

Karger

Access to resources Recommend Favorite

The contribution of pain in determining the health status of cancer patients with bone metastases: A secondary analysis of data from three Phase III registration trials

By  

EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol. 22, Iss. 3, 2018-03 ,pp. : 565-571

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Study with 3rd- or 4th-Line Bendamustine (Flat Dose) Therapy in Patients with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 32, Iss. 8-9, 2009-07 ,pp. : 488-492

Karger

Access to resources Recommend Favorite

Treatment options for breast cancer and bone metastases

By Pecherstorfer Martin  

Women's Health, Vol. 5, Iss. 2, 2009-03 ,pp. : 149-163

Future Medicine

Access to resources Recommend Favorite